The company will manufacture five million doses of avian flu vaccine in the first quarter of 2025 at its UK plant.
The company will manufacture five million doses of avian flu vaccine in the first quarter of 2025 at its UK plant.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.